Skip to main content
Figure 3 | BMC Musculoskeletal Disorders

Figure 3

From: Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study

Figure 3

IRRs during or within 24 hours of each rituximab infusion. IRR, infusion-related reaction, RTX, rituximab. Error bars are 95% CI of the percentage. aWeighted average of incidences reported in historical integrated data of phase 2 and phase 3 studies and open-label extension to date, adjusted for the proportion of patients with 0, 1, or 2 courses of prior rituximab.

Back to article page